Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2019, Article ID 6076923, 4 pages
https://doi.org/10.1155/2019/6076923
Case Report

Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban

1Department of Internal Medicine, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave., Chicago, IL 60657, USA
2Department of Internal Medicine, Flushing Hospital Medical Center, 4500 Parsons Blvd, Flushing, NY 11355, USA
3Department of Cardiology, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave, Chicago, IL 60657, USA

Correspondence should be addressed to Safwan Gaznabi; moc.liamg@ibanzags

Received 16 November 2018; Accepted 20 February 2019; Published 9 April 2019

Academic Editor: Aiden Abidov

Copyright © 2019 Safwan Gaznabi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. S. Chugh, R. Havmoeller, K. Narayanan et al., “Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study,” Circulation, vol. 129, no. 8, pp. 837–847, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Brickner, D. B. Friedman, C. G. Cigarroa, and P. A. Grayburn, “Relation of thrombus in the left atrial appendage by transesophageal echocardiography to clinical risk factors for thrombus formation,” The American Journal of Cardiology, vol. 74, no. 4, pp. 391–393, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Kamp, “Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation,” European Heart Journal, vol. 20, no. 13, pp. 979–985, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. C. T. Ruff, R. P. Giugliano, E. Braunwald et al., “Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a metaanalysis of randomised trials,” The Lancet, vol. 383, no. 9921, pp. 955–962, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Salazar, D. D. Aguila, and E. G. Cordova, “Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with non-valvular atrial fibrillation,” Cochrane Database of Systematic Reviews, no. 3, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members et al., “Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC),” European Heart Journal, vol. 31, no. 19, pp. 2369–2429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kirchhof, S. Benussi, D. Kotecha et al., “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS,” European Heart Journal, vol. 37, no. 38, pp. 2893–2962, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Corrado, G. Tadeo, S. Beretta et al., “Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation,” Chest, vol. 115, no. 1, pp. 140–143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. U. O. Egolum, D. G. Stover, D. Lenihan et al., “Intracardiac thrombus: diagnosis, complications and management,” The American Journal of the Medical Sciences, vol. 345, no. 5, pp. 391–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Delewi, F. Zijlstra, and J. J. Piek, “Left ventricular thrombus formation after acute myocardial infarction,” Heart, vol. 98, no. 23, pp. 1743–1749, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Patel, K. W. Mahaffey, J. Garg et al., “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” New England Journal of Medicine, vol. 365, no. 10, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Steffel, P. Verhamme, T. S. Potpara et al., “The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation,” European Heart Journal, vol. 39, no. 16, pp. 1330–1393, 2018. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Y. Lip, C. Hammerstingl, F. Marin et al., “Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF),” American Heart Journal, vol. 178, pp. 126–134, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Y. H. Lip, C. Hammerstingl, F. Marin et al., “Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF),” American Heart Journal, vol. 169, no. 4, pp. 464–471.e2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Dobashi, T. Fujino, and T. Ikeda, “Use of apixaban for an elderly patient with left atrial thrombus,” BMJ Case Reports, vol. 2014, no. 1, article bcr2014203870, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Agarwal, R. Hachamovitch, and V. Menon, “Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis,” Archives of Internal Medicine, vol. 172, no. 8, pp. 623–631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. S. Mearns, C. M. White, C. G. Kohn et al., “Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression,” Thrombosis Journal, vol. 12, no. 1, p. 14, 2014. View at Publisher · View at Google Scholar · View at Scopus